Protein kinase C modulation and anticancer drug response

Cancer Investigation

Volumn 18, Issue 8, 2000, Pages 731-739

  Cartee, L ^a   Kucera, G L ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN KINASE C;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CELL DEATH; ENZYME ACTIVATION; MALIGNANT TRANSFORMATION; PLEIOTROPY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TARGET CELL;

EID: 0033676490     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357900009012205     Document Type: Review

References (99)

1. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel
2. Modulation of cisplatin sensitivity and growth rate of an ovarian carcinoma cell line by bombesin and tumor necrosis factor-alpha
3. Enhancement of sensitivity to platinum(II)-containing drugs by 12-0-tetradecanoyl-phorbol-13-acetate in a human ovarian carcinoma cell line
4. Protein kinase C and tyrosine kinase activities affect taxol induced apoptosis in human leukemia cells
5. Death receptors: Signaling and modulation
6. Mitochondria and apoptosis
7. Caspases: Enemies within
8. A matter of life and cell death
9. The Bcl-2 protein family: Arbiters of cell survival
10. Mechanisms of apoptosis avoidance in cancer
11. Apoptosis: An overview
12. Biology of the protein kinase C family
13. The potential for isoenzyme-selective modulation of protein kinase C
14. Regulation of protein kinase C
15. Protein kinase C isoenzymes: Divergence in signal transduction?
16. Proteolytic activation of calcium-activated, phospholipid-dependent protein kinase by calcium-dependent neutral protease
17. The complete primary structure of protein kinase C - The major phorbol ester receptor
18. Protein kinase C is regulated in vivo by three functionally distinct phosphorylations
19. The protein kinase C and protein kinase C related gene families
20. Protein kinase C (PKC)-induced PKC degradation: A model for down-regulation
21. Activation of protein kinase C triggers its ubiquitination and degradation
22. Ubiquitination of protein kinase C-alpha and degradation by the proteasome
23. 2-, phosphatidylinositol and phosphatidylinositol 4,5-bisphosphate
24. 3
25. Interaction cloning of protein kinase C substrates
26. Identification of a major protein kinase C-binding protein and substrate in rat embryo fibroblasts. Decreased expression in transformed cells
27. Protein kinase C domains involved in interactions with other proteins
28. Protein kinase C isozymes and substrates
29. Identification of phosphatidylcholine-selective and phosphatidylinositol-selective phospholipases D in Madin-Darby canine kidney cells
30. Isolation and characterization of delta-subspecies of protein kinase C from rat brain
31. Involvement of protein kinase C-in glucocorticoid-induced apoptosis in thymocytes
32. The role of protein kinase C in myeloid cell apoptosis
33. Overexpression of protein kinase C isoenzymes alpha, beta I, gamma, and epsilon in cells overexpressing the insulin receptor. Effects on receptors phosphorylation and signaling
34. Functional divergence of protein kinase C (PKC) family members. PKC gamma differs from PKC alpha and beta II and nPKC epsilon in its competence to mediate 12-0-tetradecanoyl phorbol 13-acetate (TPA)-responsive transcriptional activation through a TPA-response element
35. Phorbol ester-induced myeloid differentiation is mediated by protein kinase C-alpha and -delta and not by protein kinase C-beta II, -epsilon, -zeta, and -eta
36. Intracellular signal modulation - A pivotal role for protein kinase C
37. Identification and localization of an actin-binding motif that is unique to the epsilon isoform of protein kinase C and participates in the regulation of synaptic function
38. Protein kinase C beta II specifically binds to and is activated by F-actin
39. Protein kinase C - A worth-while target for anticancer drugs
40. Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters
41. Phorbol diester receptor copurifies with protein kinase C
42. Induction of apoptosis in chronic lymphocytic leukemia cells and its prevention by phorbol ester
43. Apoptosis of human leukemic HL- 60 cells induced to differentiate by phorbol ester treatment
44. Modulation of cellular processes by H7, a non-selective inhibitor of protein kinases
45. The bryostatins inhibit growth of B16/F10 melanoma cells in vitro through a protein kinase C-independent mechanism: Dissociation of activities using 26-epibryostatin 1
46. Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl- 2
47. Gemcitabine induces programmed cell death and activates protein kinase C in BG- 1 human ovarian cancer cells
48. Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-β-D-arabinofuranosylcytosine
49. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/ interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1
50. Enhanced hematopoietic activity of a human granulocyte/macrophage colony-stimulating factor-interleukin 3 fusion protein
51. Inhibition of Akt kinase by cell-permeable ceramide and its implications for ceramide-induced apoptosis
52. Involvement of stress-activated protein kinase and p38/RK mitogen-activated protein kinase signaling pathways in the enhanced phosphorylation of initiation factor 4E in NIH 3T3 cells
53. Differential regulation of discrete apoptotic pathways by Ras
54. Overexpression of protein kinase C isoform epsilon but not delta in human interleukin-3-dependent cells suppresses apoptosis and induces bcl- 2 expression
55. Atypical protein kinase C iota protects human leukemia cells against drug-induced apoptosis
56. Positioning atypical protein kinase C isoforms in the UV-induced apoptotic signaling cascade
57. The product of par-4, a gene induced during apoptosis, interacts selectively with the atypical isoforms of protein kinase C
58. The proteolytic cleavage of protein kinase C isotypes, which generates kinase and regulatory fragments, correlates with Fas- mediated and 12-O-tetradecanoyl-phorbol-13-acetate-induced apoptosis
59. Activation of protein kinase Cdelta in human myeloid leukemia cells treated with 1-beta-D-arabinofuranosylcytosine
60. Caspase-3-mediated cleavage of protein kinase C theta in induction of apoptosis
61. The effects of gemcitabine and TPA on PKC signaling in BG- 1 human ovarian cancer cells
62. Programmed cell death and the proteosome pathway
63. Linking protein kinase C to cell-cycle control
64. Mitogen-activated protein (MAP) kinase regulates production of tumor necrosis factor-alpha and release of arachidonic acid in mast cells. Indications of communication between p 38 and p42 MAP kinases
65. Differential effects of phorbol ester on apoptosis in HL- 60 promyelocytic leukemia cells
66. Differential regulation of protein kinase C isozymes by bryostatin I and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts
67. Specific binding of phorbol ester tumor promoters
68. Competitive inhibition by diacylglycerol of specific phorbol ester binding
69. The potential of protein kinase C as a target for anticancer treatment
70. Phorbol ester treatment of U 937 cells with altered protein kinase C content and distribution induces cell death rather than differentiation
71. Doppa induces cell death but not differentiation of U937 cells: Evidence for the involvement of PKC-beta 1 in the regulation of apoptosis
72. Extracellular signal-regulated kinase (ERK) activity is required for TPA-mediated inhibition of drug-induced apoptosis
73. Induction of cyclooxygenase-2 by the activated MEKK1-SEK1/MKK4-p38 mitogen-activated protein kinase pathway
74. The large-scale isolation of bryostatin 1 from Bugula neritina following current good manufacturing practices
75. 3H]bryostatin 4 to protein kinase C
76. 3H]bryostatin 1 and analogs to calcium-dependent and calcium-independent protein kinase C isozymes
77. A phase I study of intravenous bryostatin 1 in patients with advanced cancer
78. Differential effects of bryostatin 1 and phorbol diester on human breast cancer cell lines
79. Phorbol esters induce death in MCF-7 breast cancer ceils with altered expression of protein kinase C isoforms. Role for p53- independent induction of gadd- 45 in initiating death
80. Bryostatin 1 induces biphasic activation of protein kinase D in intact cells
81. Potentiation of the activity of 1-β-D-arabinofuranosylcytosine by the protein kinase C activator bryostatin 1 in HL- 60 cells
82. Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[β-D-arabinofnranosyl]cytosine-induced apoptosis in HL- 60 human promyelocytic leukemia cells
83. Sensitization of human cervical carcinoma cells to cis-diamminedichloroplatinum(II) by bryostatin 1
84. Bryostatin 1 potentiates 1-beta-D-arabinofuranosylcytosine-mediated antiproliferative effects in c-Jun dominant-negative human myeloid leukemia cells (U937/TAM67) through a nonapoptotic mechanism
85. A new alkaloid AM-2282 OF Streptomyces origin. Taxonomy, fermentation, isolation and preliminary characterization
86. Use and specificity of staurosporine, UCN- 01, and calphostin C as protein kinase inhibitors
87. Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C
88. Cellular relocalisation of protein kinase C-theta caused by staurosporine and some of its analogues
89. Tumor necrosis factor signaling to stress-activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK) and p38. Germinal center kinase couples traf2 to mitogen-activated protein kinase/erk kinase kinase 1 and sapk while receptor interacting protein associates with a mitogen- activated protein kinase kinase kinase upstream of mkk 6 and p38
90. Prostaglandin F2alpha (PGF2alpha) and the isoprostane, 8,12-iso-isoprostane F2alpha-III, induce cardiomyocyte hypertrophy. Differential activation of downstream signaling pathways
91. Inhibition of activator protein 1 activity and neoplastic transformation by aspirin
92. Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss
93. Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity
94. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C
95. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976
96. Calphostins (UCN-1028), novel and specific inhibitors of protein kinase C. I. Fermentation, isolation, physico-chemical properties and biological activities
97. Induction of apoptotic DNA fragmentation and cell death in HL- 60 human promyelocytic leukemia cells by pharmacological inhibitors of protein kinase C
98. Antisense oligonucleotide inhibitors of isozymes of protein kinase C: In vitro and in vivo activity, and clinical development as anti-cancer therapeutics
99. Molecular ordering in HIV-induced apoptosis. Oxidative stress, activation of caspases, and cell survival are regulated by transaldolase